GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

narsoplimab   Click here for help

GtoPdb Ligand ID: 14317

Synonyms: narsoplimab-wuug | OMS-721 | OMS721 | Yartemlea®
Approved drug
narsoplimab is an approved drug
Compound class: Antibody
Comment: Narsoplimab (OMS721) is a fully human IgG4 monoclonal antibody against mannan-binding lectin-associated serine protease 2 (MASP-2) [2].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
Classification Click here for help
Compound class Antibody
Approved drug? Yes. US FDA (2025)
International Nonproprietary Names Click here for help
INN number INN
11174 narsoplimab
Synonyms Click here for help
narsoplimab-wuug | OMS-721 | OMS721 | Yartemlea®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 780
Other databases
GtoPdb PubChem SID 523352109
Search PubMed clinical trials narsoplimab
Search PubMed titles narsoplimab
Search PubMed titles/abstracts narsoplimab